Okedi (Risperidone)

Risperidone, the active ingredient in Okedi, is a antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Okedi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Okedi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Okedi (risperidone) acts on dopamine pathways and is indicated for several psychiatric conditions.

- Schizophrenia: Reduces hallucinations, delusions and thought disorder. - Bipolar I disorder: Helps stabilize mood and prevent manic episodes. - Irritable‑behaviour associated with autistic spectrum disorder: Improves irritability and aggression. - Tourette syndrome: Decreases frequency and severity of motor and vocal tics. - Early‑onset schizophrenia:   -   t